SeeColors App Helps People with Color Vision Deficiency Calibrate Their TVs to Their Needs

November 2017 - Samsung has launched a new app, called SeeColors, that allows its QLED TVs to provide a more accurate viewing experience for users with color vision deficiency (CVD). CVD affects around 300 million people around the world, though many cases may go undiagnosed as most people with CVD don’t know they have it. Users can use the app to adjust the color spectrum on their TV. SeeColors caters to their unique CVD needs and calibrates the TV appropriately. This allows once muted or invisible colors to be seen in their full splendor. In a press release, Hyeongnam Kim, Vice President of the Visual Display Business at Samsung Electronics said, “Samsung is committed to making people’s everyday lives smarter and more convenient through technology and innovation. The launch of SeeColors for QLED TV embodies this mission by providing users with a way to address one of the world’s biggest optical challenges through the latest technologies and visual displays.” Samsung has won the CES Innovation Award for four years, starting in 2015, and this latest partnership continues this trend.
 
The app was built in collaboration between Samsung and Colorlite, a Hungarian company with a background in crafting high-quality lenses and correcting visual impairments. The mathematical modeling used by the app to identify a user’s CVD was developed by the Department of Mechatronics, Optics and Mechanical Engineering Informatics at the Budapest University of Technology. The SeeColors app can be downloaded from the Google Play store and its own Galaxy App Store for compatible devices. Source: Samsung.

Disclaimer

The contents of this website were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90RE5025-01-00). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this website do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.